← Leaderboards
Erin E Doherty
University Of California At Davis
$187,549
Attributed
$187,549
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $75.5K · FY2021–25$100K$75K$50K$25K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$187,549 · 2
By mechanism
F32$149,348 · 1
F31$38,201 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Jing Hong Wang$12,171,384
- Rebecka Jane Sepela$315,293
- Judy A. Van De Water$11,055,727
- Alice F Tarantal$43,386,026
- Stephen Charles Noctor$4,091,635
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationDesignSiteCellsGuide RnaEnzymesMediatingResponseBaseSuccessModificationDrada2b ProteinBiologyGenetic VariantBase EditorDsrna Adenosine DeaminaseGenomeAmino Acid SubstitutionCell TherapyAutologous TransplantationDna-Binding ProteinsClinicClinically RelevantDeamination
Grant awards (3)
Precision Deaminases to Expand the Scope of Diseases Amenable to CRISPR-mediated Correction$75,520
F32 · FY2025 · GM · contact PI
Precision Deaminases to Expand the Scope of Diseases Amenable to CRISPR-mediated Correction$73,828
F32 · FY2024 · GM · contact PI
Site-directed RNA Editing to Modulate Kinase Activity as a Chemotherapeutic$38,201
F31 · FY2021 · CA · contact PI